AJANTPHARM.NS Valuations

Quarterly trend of key valuation metrics

Metric	Current (TTM) TTM Baseline	Q2 '26 30.06.2026	Q1 '26 31.03.2026
Market & Enterprise Value
Market Cap	426.12B EUR	427.64B EUR	350.46B EUR
Enterprise Value	422.07B EUR	427.64B EUR	352.03B EUR
Valuation Multiples
Trailing P/E	37.56x	37.84x	34.32x
Forward P/E	29.27x	--	--
Price to Sales	7.38x	7.47x	6.65x
Price to Book	9.41x	--	7.74x
EV/Revenue	7.31x	7.47x	6.68x
EV/EBITDA	26.99x	25.54x	23.55x
Price to FCF (P/FCF)	--	--	--
EV/FCF	--	--	--
FCF Yield	--	--	--